See studies
Back to all studies
RecruitingNCT07300969

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

This recruiting study focuses on depression and currently lists sites or participation links in United Kingdom, United States.

DepressionOtherFrom 18 Years to 75 Years
In plain English

Key information made simple

This study exists to learn from real-world information that can show how the medication DT-101 fits into care. Researchers are trying to understand whether the medication DT-101 can give earlier or clearer feedback during care. For people living with Depression, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could lead to earlier recognition and more informed decisions later on. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Draig Clinical Site in Bentonville, Draig Clinical Site in Little Rock, and Draig Clinical Site in Oceanside. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis, while common reasons not to take part include pregnancy or breastfeeding and major medical issues that could make participation unsuitable. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT07300969. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in United Kingdom.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com